Cigna Corporation (NYSE:CI) had its price objective boosted by Citigroup Inc. from $185.00 to $198.00 in a research report sent to investors on Monday morning. They currently have a buy rating on the health services provider’s stock.

Other equities analysts also recently issued research reports about the company. ValuEngine upgraded Cigna Corporation from a hold rating to a buy rating in a report on Friday, June 2nd. Jefferies Group LLC increased their price target on Cigna Corporation from $178.00 to $183.00 and gave the company a buy rating in a report on Monday, May 15th. Deutsche Bank AG increased their price target on Cigna Corporation from $172.00 to $175.00 and gave the company a buy rating in a report on Wednesday, May 10th. Stifel Nicolaus increased their price target on Cigna Corporation from $170.00 to $175.00 and gave the company a buy rating in a report on Monday, May 15th. Finally, Zacks Investment Research upgraded Cigna Corporation from a hold rating to a buy rating and set a $175.00 price target on the stock in a report on Tuesday, April 25th. Three equities research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the stock. The stock currently has an average rating of Buy and an average target price of $179.89.

Cigna Corporation (CI) traded down 0.01% on Monday, hitting $175.97. 161,978 shares of the stock were exchanged. The company’s 50 day moving average price is $170.76 and its 200-day moving average price is $157.68. Cigna Corporation has a one year low of $115.03 and a one year high of $176.00. The company has a market cap of $45.05 billion, a P/E ratio of 23.49 and a beta of 0.46.

Cigna Corporation (NYSE:CI) last announced its quarterly earnings results on Friday, August 4th. The health services provider reported $2.91 EPS for the quarter, beating the consensus estimate of $2.48 by $0.43. Cigna Corporation had a return on equity of 17.58% and a net margin of 7.46%. The company had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.26 billion. During the same quarter last year, the company posted $1.98 earnings per share. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. Equities research analysts predict that Cigna Corporation will post $9.95 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This story was first posted by Daily Political and is the property of of Daily Political. If you are reading this story on another site, it was illegally copied and reposted in violation of United States and international trademark & copyright legislation. The original version of this story can be accessed at https://www.dailypolitical.com/2017/08/08/cigna-corporation-nyseci-price-target-raised-to-198-00-at-citigroup-inc.html.

In related news, EVP Lisa R. Bacus sold 11,455 shares of the firm’s stock in a transaction on Wednesday, May 24th. The stock was sold at an average price of $161.57, for a total value of $1,850,784.35. Following the completion of the transaction, the executive vice president now directly owns 24,753 shares of the company’s stock, valued at $3,999,342.21. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Nicole S. Jones sold 20,312 shares of the firm’s stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $160.04, for a total value of $3,250,732.48. Following the completion of the transaction, the executive vice president now directly owns 44,737 shares of the company’s stock, valued at $7,159,709.48. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 219,558 shares of company stock valued at $37,135,665. 1.30% of the stock is owned by company insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of CI. American Beacon Advisors Inc. purchased a new position in shares of Cigna Corporation during the first quarter valued at approximately $102,000. Baystate Wealth Management LLC boosted its position in shares of Cigna Corporation by 436.1% in the first quarter. Baystate Wealth Management LLC now owns 772 shares of the health services provider’s stock valued at $116,000 after buying an additional 628 shares during the period. Founders Capital Management purchased a new position in shares of Cigna Corporation during the first quarter valued at approximately $117,000. Mckinley Capital Management LLC Delaware purchased a new position in shares of Cigna Corporation during the first quarter valued at approximately $122,000. Finally, Parallel Advisors LLC boosted its position in shares of Cigna Corporation by 62.3% in the second quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock valued at $139,000 after buying an additional 307 shares during the period. 86.91% of the stock is owned by hedge funds and other institutional investors.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Analyst Recommendations for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.